IQV IQVIA
- Official Name: IQVIA HOLDINGS INC
- Headquarters: 2400 ELLIS ROAD, DURHAM, NC, 27703 US
- CEO: Ari Bousbib
- Website: iqvia.com
Match Results
| Date | League | Week | Opponent | Result | Score |
|---|---|---|---|---|---|
| 2025-07-14 | 1 | Lost by 0.109 | 0.858 - 0.967 | ||
| 2025-07-15 | 1R | Won by 2.238 | (0.318) - (2.556) | ||
| 2025-07-21 | 2 | Won by 0.385 | (2.363) - (2.748) | ||
| 2025-07-23 | 1R | Won by 3.169 | 5.404 - 2.235 | ||
| 2025-07-28 | 3 | Won by 19.373 TOTW | 24.728 - 5.355 | ||
| 2025-07-29 | 2R | Lost by 3.374 | (1.543) - 1.831 | ||
| 2025-08-04 | 4 | Lost by 6.277 | (7.569) - (1.292) | ||
| 2025-08-06 | 2R | Lost by 1.937 | (2.871) - (0.934) | ||
| 2025-08-07 | 1R | Lost by 6.397 | 0.748 - 7.145 | ||
| 2025-08-11 | 5 | Won by 1.239 | (1.717) - (2.956) | ||
| 2025-08-18 | 6 | Lost by 3.807 | 5.968 - 9.775 | ||
| 2025-08-25 | 7 | Lost by 5.153 | (3.341) - 1.812 | ||
| 2025-09-01 | 8 | Lost by 0.975 | 1.934 - 2.909 | ||
| 2025-09-08 | 9 | Lost by 5.372 | (1.795) - 3.577 | ||
| 2025-09-15 | 10 | Lost by 2.668 | (0.968) - 1.700 | ||
| 2025-09-22 | 11 | Lost by 0.054 | 0.990 - 1.044 | ||
| 2025-09-29 | 12 | Lost by 3.056 | (3.836) - (0.780) | ||
| 2025-10-06 | 13 | Won by 16.561 TOTW | 12.024 - (4.537) | ||
| 2025-10-13 | 14 | Lost by 0.034 | (0.605) - (0.571) | ||
| 2025-10-20 | 15 | Won by 1.653 | 3.832 - 2.179 |
Latest News

3 Low-Volatility Stocks with Questionable Fundamentals
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss ...

IQVIA: A $34.2 Billion Backlog Does Not Guarantee Faster Earnings Growth
IQVIA Holdings (IQV) reported robust Q2 2026 results, with 8.7% revenue growth and a 19% increase in Research & Development Solutions bookings.

IQVIA Holdings (IQV) Gains as Improving Demand Environment and High Win Rates
Harris Oakmark recently released its third-quarter 2026 investor letter for its “Oakmark Global Fund”. The letter can be downloaded here. The Fund...

VEEV Expands IQVIA Partnership With Clinical Operations Software Suite
Veeva expands its IQVIA partnership with clinical operations software, boosting its market reach and growth prospects through wider adoption and integ...
Stifel Maintains Buy on IQVIA Holdings, Raises Price Target to $303
Stifel analyst Shlomo Rosenbaum maintains IQVIA Holdings (NYSE:IQV) with a Buy and raises the price target from $276 to $303.

IQVIA Selects Veeva Clinical Operations Applications
IQVIA (NYSE: IQV) and Veeva Systems (NYSE: VEEV) today announced an expansion of their partnership with the selection of Veeva CTMS, eTMF, Study Start...
IQVIA Expands Partnership Veeva Systems On Enterprise Standard Applications That Will Be Used Across IQVIA Clinical Development Studies
IQVIA (NYSE:IQV) and Veeva Systems (NYSE:VEEV) today announced an expansion of their partnership with the selection of Veeva CTMS, eTMF, Study Startup...